FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309507382> ?p ?o ?g. }

• W4309507382 endingPage "222" @default.
• W4309507382 startingPage "213" @default.
• W4309507382 abstract "In symptomatic patients with heart failure and reduced ejection fraction (HFrEF), recent international guidelines recommend initiating four major therapeutic classes rather than sequential initiation. It remains unclear how this change in guidelines is perceived by practicing cardiologists versus heart failure (HF) specialists.An independent academic web-based survey was designed by a group of HF specialists and posted by email and through various social networks to a broad community of cardiologists worldwide 1 year after the publication of the latest European HF guidelines. Overall, 615 cardiologists (38 [32-47] years old, 63% male) completed the survey, of which 58% were working in a university hospital and 26% were HF specialists. The threshold to define HFrEF was ≤40% for 61% of the physicians. Preferred drug prescription for the sequential approach was angiotensin-converting enzyme inhibitors or angiotensin receptor-neprilysin inhibitors first (74%), beta-blockers second (55%), mineralocorticoid receptor antagonists third (52%), and sodium-glucose cotransporter 2 inhibitors (53%) fourth. Eighty-four percent of participants felt that starting all four classes was feasible within the initial hospitalization, and 58% felt that titration is less important than introducing a new class. Age, status in training, and specialization in HF field were the principal characteristics that significantly impacted the answers.In a broad international cardiology community, the 'historical approach' to HFrEF therapies remains the preferred sequencing approach. However, accelerated introduction and uptitration are also major treatment goals. Strategy trials in treatment guidance are needed to further change practices." @default.
• W4309507382 created "2022-11-28" @default.
• W4309507382 creator A5001909775 @default.
• W4309507382 creator A5004085293 @default.
• W4309507382 creator A5004138231 @default.
• W4309507382 creator A5006169619 @default.
• W4309507382 creator A5008530481 @default.
• W4309507382 creator A5013259163 @default.
• W4309507382 creator A5017341652 @default.
• W4309507382 creator A5019637562 @default.
• W4309507382 creator A5021743832 @default.
• W4309507382 creator A5022272687 @default.
• W4309507382 creator A5023091612 @default.
• W4309507382 creator A5024590968 @default.
• W4309507382 creator A5035015657 @default.
• W4309507382 creator A5038434986 @default.
• W4309507382 creator A5039936186 @default.
• W4309507382 creator A5043342074 @default.
• W4309507382 creator A5045836619 @default.
• W4309507382 creator A5047834835 @default.
• W4309507382 creator A5051536922 @default.
• W4309507382 creator A5053303683 @default.
• W4309507382 creator A5063376319 @default.
• W4309507382 creator A5068884647 @default.
• W4309507382 creator A5069917976 @default.
• W4309507382 creator A5070623406 @default.
• W4309507382 creator A5071236494 @default.
• W4309507382 creator A5071237766 @default.
• W4309507382 creator A5073303566 @default.
• W4309507382 creator A5077729845 @default.
• W4309507382 creator A5078228789 @default.
• W4309507382 creator A5082158909 @default.
• W4309507382 creator A5082970378 @default.
• W4309507382 creator A5083465549 @default.
• W4309507382 creator A5086624399 @default.
• W4309507382 creator A5088850609 @default.
• W4309507382 creator A5088944275 @default.
• W4309507382 date "2022-11-23" @default.
• W4309507382 modified "2023-10-14" @default.
• W4309507382 title "Sequencing and titrating approach of therapy in heart failure with reduced ejection fraction following the 2021 European Society of Cardiology guidelines: an international cardiology survey" @default.
• W4309507382 cites W2129711762 @default.
• W4309507382 cites W2790275265 @default.
• W4309507382 cites W2903924542 @default.
• W4309507382 cites W2968457669 @default.
• W4309507382 cites W2989425857 @default.
• W4309507382 cites W3026507424 @default.
• W4309507382 cites W3037737029 @default.
• W4309507382 cites W3043874048 @default.
• W4309507382 cites W3045021447 @default.
• W4309507382 cites W3081830235 @default.
• W4309507382 cites W3115836333 @default.
• W4309507382 cites W3132494856 @default.
• W4309507382 cites W3135263240 @default.
• W4309507382 cites W3193297191 @default.
• W4309507382 cites W4210520398 @default.
• W4309507382 cites W4220904096 @default.
• W4309507382 cites W4224870226 @default.
• W4309507382 cites W4293354639 @default.
• W4309507382 cites W4293860347 @default.
• W4309507382 doi "https://doi.org/10.1002/ejhf.2743" @default.
• W4309507382 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36404398" @default.
• W4309507382 hasPublicationYear "2022" @default.
• W4309507382 type Work @default.
• W4309507382 citedByCount "8" @default.
• W4309507382 countsByYear W43095073822023 @default.
• W4309507382 crossrefType "journal-article" @default.
• W4309507382 hasAuthorship W4309507382A5001909775 @default.
• W4309507382 hasAuthorship W4309507382A5004085293 @default.
• W4309507382 hasAuthorship W4309507382A5004138231 @default.
• W4309507382 hasAuthorship W4309507382A5006169619 @default.
• W4309507382 hasAuthorship W4309507382A5008530481 @default.
• W4309507382 hasAuthorship W4309507382A5013259163 @default.
• W4309507382 hasAuthorship W4309507382A5017341652 @default.
• W4309507382 hasAuthorship W4309507382A5019637562 @default.
• W4309507382 hasAuthorship W4309507382A5021743832 @default.
• W4309507382 hasAuthorship W4309507382A5022272687 @default.
• W4309507382 hasAuthorship W4309507382A5023091612 @default.
• W4309507382 hasAuthorship W4309507382A5024590968 @default.
• W4309507382 hasAuthorship W4309507382A5035015657 @default.
• W4309507382 hasAuthorship W4309507382A5038434986 @default.
• W4309507382 hasAuthorship W4309507382A5039936186 @default.
• W4309507382 hasAuthorship W4309507382A5043342074 @default.
• W4309507382 hasAuthorship W4309507382A5045836619 @default.
• W4309507382 hasAuthorship W4309507382A5047834835 @default.
• W4309507382 hasAuthorship W4309507382A5051536922 @default.
• W4309507382 hasAuthorship W4309507382A5053303683 @default.
• W4309507382 hasAuthorship W4309507382A5063376319 @default.
• W4309507382 hasAuthorship W4309507382A5068884647 @default.
• W4309507382 hasAuthorship W4309507382A5069917976 @default.
• W4309507382 hasAuthorship W4309507382A5070623406 @default.
• W4309507382 hasAuthorship W4309507382A5071236494 @default.
• W4309507382 hasAuthorship W4309507382A5071237766 @default.
• W4309507382 hasAuthorship W4309507382A5073303566 @default.
• W4309507382 hasAuthorship W4309507382A5077729845 @default.
• W4309507382 hasAuthorship W4309507382A5078228789 @default.
• W4309507382 hasAuthorship W4309507382A5082158909 @default.
• W4309507382 hasAuthorship W4309507382A5082970378 @default.
• W4309507382 hasAuthorship W4309507382A5083465549 @default.

• next